MétaCan
Menu
Back to cohort

Improvement in health related quality of life in infliximab-treated moderate-tosevere active ulcerative colitis patients: Improvement overall and by baseline disease activity

2007· article· en· W4238730570 on OpenAlexaff
B Sands, B Feagan, S Yan, W Sandborn, P Rutgeerts, D Eisenberg, M Bala, J Johanns, S Hanauer, W Reinisch

Bibliographic record

VenueInflammatory Bowel Diseases · 2007
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsRobarts Clinical Trials
Fundersnot available
KeywordsMedicineUlcerative colitisInfliximabInternal medicineQuality of life (healthcare)GastroenterologyPhysical therapyDisease

Abstract

fetched live from OpenAlex

To evaluate the long-term effect of IFX on health related quality of life (HRQL) in pts with moderate-to-severe active UC in ACT 1. The relationship between baseline disease activity (measured by the Mayo Clinic score) and the magnitude of improvement in HRQL (data from ACT 1 and ACT 2) was examined. Pts with moderate-to-severe active UC (baseline Mayo score between 6 and 12, inclusive) were enrolled in ACT 1 (n=364) and ACT 2 (n=364). Pts were randomized (1:1:1) to PBO, IFX 5, or 10 mg/kg at baseline, wks 2, 6, and q8 wks through wk 22 in ACT 2 and through wk46 in ACT 1. HRQL was assessed using the IBDQ and the SF-36,with Physical and Mental Component Summaries (PCS, MCS) at baseline, wks 8, and 30 (ACT 1 and ACT 2), and at wk 54 (ACT 1). Results at 1-yr are reported for ACT 1 and analyses using data from the combined trials were used to determine the improvement in HRQL by baseline disease severity [Mayo score (moderate UC: UC outpts with Mayo score<10; severe UC: UC outpts with Mayo score ≥10)]. Analysis of variance on van der Waerden scores was used to compare groups. In ACT 1, at wk 54, the IFX groups had > improvements from baseline than PBO (p<0.05 except for MCS in the 5 mg/kg group), with the following comparisons [mean (median)] between the combined IFX group vs PBO: Total IBDQ [32 (23) vs 13 (0.0)], PCS [6.0 (2.5) vs 2.7 (0.0)], and MCS [5.1 (0.0) vs 1.3 (0.0)]. All 4 IBDQ dimensions and all 8 scales of the SF-36 also showed > improvements in the combined IFX group vs PBO (p<0.05). Moderate UC pts had higher baseline scores in the IBDQ and PCS and MCS, than those with severe UC (Table). In both severity groups, there was a > improvement in all 3 HRQL scores in the combined IFX group vs PBO, at both wk 8 and 30. The magnitude of improvement in HRQL was similar regardless of baseline disease severity. Mean baseline score and mean improvement from baseline at wks 8 and 30 Pts with moderate-to-severe active UC had significant improvement in HRQL through 1-yr of IFX treatment. IFX treatment results in consistent improvement in HRQL in pts with UC, irrespective of baseline disease severity.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.253
Teacher spread0.245 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2007
Admission routes1
Has abstractyes

Explore more

Same venueInflammatory Bowel DiseasesSame topicInflammatory Bowel DiseaseFrench-language works237,207